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Introduction
Recent studies have proposed two major hypotheses for the mechanism leading to the importance of podocyte depletion resulting from apoptosis as a causative factor for the onset of proteinuria and glomerular sclerosis [1] [2] [3] . According to this hypothesis, the reduced podocyte number in glomeruli is attributed to the apoptotic death of these cells. Another hypothesis for podocyte injury proposes that injured podocytes obtain a motile ability facilitating their detachment from the glomerular basement membrane rather than apoptotic cell death, where podocytes are able to undergo an epithelial-to-mesenchymal transition (EMT) process when they are challenged by different injurious stimuli such as transforming indicated by reduced level of podocyte-derived proteins such as nephrin, P-cadherin (P-cad), injury and sclerosis [12, 13] . However, it remains poorly understood how podocyte EMT is activated and regulated in response to different pathological stimuli.
known that autophagy is a cell survival mechanism responsible for the degradation of longphysiological conditions, autophagy functions in a continuous, reparative way to maintain critical role in maintenance of autophagic process, keeping podocytes in a differentiated and and that lysosome dysfunction or injury due to derangement of its regulatory mechanisms or enhances podocyte EMT.
aggregation, and activation of associated signaling pathways such as Nrf2-mediated redox inhibition by V-ATPase inhibitor and its siRNA induces EMT in podocytes by observations of changes in epithelial and mesenchymal markers. Then, we tested whether lysosome function 
Results
To determine whether lysosome function inhibition has effects on EMT in podocytes, enhancement of EMT in podocytes.
The effects of lysosome functional inhibition on EMT in podocytes were further detected 
Discussion
The major goals of the present study were to determine whether lysosome dysfunctionare degraded by autophagic process and to explore the mechanisms by which accumulation found that lysosome function inhibition with a low dose of lysosomal V-ATPase inhibitor, explored the signaling mechanisms activating or enhancing podocyte EMT associated with differentiated and therefore the maintenance of functional and structural integrity of these cells during their long time surviving are much dependent upon the autophagic process, which includes the formation and degradation of autophagosomes [13] . This led us to be an important mechanism activating or enhancing EMT in podocytes, leading to podocyte injury and glomerular sclerosis. This hypothesis was tested in the present study by inhibition previous studies, some molecular mechanisms have been proposed to activate EMT in other cell or tissue types, which are similar to those regulating oncogenic properties in neoplastic cells such as proliferation, resistance to apoptosis and angiogenesis through transcription degradation of some signaling proteins may be one of mechanisms responsible for EMT, little is known so far how lysosome dysfunction induces EMT in many cell types including together to promote lysosomal degradation of E-cadherin instead of its recycling in tumor cells, resulting in EMT and tumor progression [19] . Despite these observations of lysosomal degradation of signaling proteins in EMT, it remains unknown how lysosomal degradation of silencing of v-ATPase gene, suggesting that lysosome function inhibition leads to abnormal accumulation may serve as a critical mechanism activating or enhancing EMT in podocytes.
have been reported to mediate the effects of death effector domain-containing DNA-binding protein (DEDD) to alter tumor growth and metastasis, suggesting that autophagy is involved podocytes. These results suggest that CDK1 phosphorylation exerts an important regulatory role on podocyte EMT and that reduced CDK1 phosphorylation may result in enhancement results provide direct evidence that this CDK1-mediated mechanism critically contributes the progression of mammalian cells through the various phases of the cell cycle [31] . Among together with these previous results provide strong evidence that reduced phosphorylation to podocyte dysfunction and injury, which may initiate podocytes injury and ultimately result in glomerulosclerosis during lysosome dysfunction. These results may direct toward prevention or treatment of glomerular sclerosis associated with lysosome dysfunction and hyperhomocysteinemia or diabetes mellitus.
